Market Size (2025)
$536.74M
Vertical: CNMBase Year: 2025
Market Size (2025)
$536.74M
Projected (2032)
$1.04B
CAGR (2022–2032)
9.9%
Key Players
10+
Protein hydrolysates are among the most widely used non-microbial plant biostimulants. They are mixtures of free amino acids, oligopeptides and polypeptides produced by partially breaking down protein-rich animal or plant materials, and are applied to crops to improve nutrient uptake, support growth and help plants cope with abiotic stress such as heat, drought and salinity.
The global protein hydrolysate biostimulants market was valued at US$ 536.7 Mn in 2025 and is projected to reach US$ 1,038.5 Mn by 2032, registering a CAGR of 9.9% over 2026–2032. Between 2022 and 2025 the market grew from US$ 402.9 Mn to US$ 536.7 Mn, a compound annual growth rate of 10.0%. Over 2025–2032 the market is projected to add US$ 501.8 Mn in value, close to doubling in size (1.93x).
Key Findings
Steady growth of close to 10% a year. The market is projected to expand at 9.9% a year over 2026–2032, broadly in line with its 10.0% pace over 2022–2025, rising from US$ 590.3 Mn in 2026 to US$ 1,038.5 Mn in 2032.
Plant-based hydrolysates gain ground. Animal-based and plant-based products each held 50.0% of the market in 2025. Plant-based products are projected to grow at 10.4% against 9.3% for animal-based, taking a 51.8% share by 2032. Demand for inputs suited to organic production, tighter scrutiny of animal-derived inputs in some markets, and the withdrawal of approvals for animal-based products in India in 2025 support this shift.
Liquids dominate. Liquid formulations accounted for 70.0% of 2025 value and are projected to grow faster (10.3% CAGR) than dry products (8.9%), reflecting their fit with foliar spraying and fertigation.
Fruits & vegetables lead; cereals & grains grow fastest. Fruits & vegetables represented 55.0% of 2025 demand. Cereals & grains, at 11.3% CAGR, is the fastest-growing crop segment and is projected to reach a 27.4% share by 2032 as biostimulant use extends from high-value horticulture into broad-acre crops.
Europe is the largest region; Asia Pacific grows fastest. Europe held 37.0% of the global market in 2025 (US$ 198.6 Mn). Asia Pacific, the second-largest region at US$ 118.1 Mn, is projected to grow at 10.9% and raise its share to 23.4% by 2032. Latin America (10.5%) and the Middle East & Africa (10.2%) also outpace the global average.
Country leaders. The U.S. was the largest single country market in 2025 at US$ 79.4 Mn, while India is the fastest-growing country at 12.8% CAGR.
Regulation is formalising the market. The EU Fertilising Products Regulation (applicable since July 2022) created a harmonised plant biostimulant category, India ended its provisional registration regime for biostimulants in June 2025, Brazil enacted a dedicated bioinputs law in December 2024, and U.S. legislation to define plant biostimulants federally was reintroduced in 2025.
Outlook
Growth over the forecast period is underpinned by the need to raise nutrient use efficiency, pressure to reduce synthetic fertiliser use in some jurisdictions, and growers' interest in tools that stabilise yield and quality under more frequent weather stress. The main constraints are inconsistent field performance across products, the cost of generating efficacy and safety data for registration, and price sensitivity in broad-acre crops. Suppliers with access to consistent feedstock, controlled hydrolysis processes and credible trial data are best placed to benefit, particularly as regulators in major markets move from loosely defined product categories to formal registration requirements.
The Protein Hydrolysate Biostimulants Market market is projected to grow at a CAGR of 9.9% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansProduct Background
Protein hydrolysates are produced by breaking the peptide bonds of proteins into shorter chains and individual amino acids. The resulting product contains a mix of free amino acids, short peptides and larger polypeptides, along with smaller amounts of carbohydrates, minerals and other compounds carried over from the raw material. The amino acid profile, the ratio of free amino acids to peptides and the size distribution of the peptides depend on the protein source and on how the hydrolysis is carried out, and these differences shape how a given product performs in the field.
Animal-derived hydrolysates are typically made from by-products of the meat, leather and fish industries, including collagen and epithelial tissue from hides and skins, blood, fish processing residues, feathers and other keratin sources. Collagen-based products are characteristically rich in glycine and proline. Plant-derived hydrolysates are made from legume seeds and biomass (for example alfalfa, soybean and pea), cereal and oilseed processing residues, and vegetable by-products, and generally have a more balanced amino acid profile.
Production Processes
After hydrolysis, the material is filtered, clarified and concentrated. Liquid products are standardised for amino acid or nitrogen content and stabilised for storage; dry products are typically produced by spray drying into soluble powders or by granulation. Enzymatic processes have gained ground because they offer better control over product composition and avoid the amino acid losses and salt load associated with harsh chemical hydrolysis.
Modes of Action
Protein hydrolysates act on plants through several routes, and products differ in which effects are most pronounced. The mechanisms most often reported in the scientific literature are:
Nitrogen and nutrient metabolism: stimulation of enzymes involved in nitrogen assimilation and improved uptake of nitrogen and other nutrients.
Signalling and hormone-like activity: some peptides, particularly in plant-derived hydrolysates, produce auxin- or gibberellin-like responses that promote root and shoot growth.
Root development: greater root length and density, which in turn improves water and nutrient capture.
Abiotic stress tolerance: amino acids such as proline and glycine contribute to osmotic adjustment and antioxidant defence under drought, salinity and temperature stress.
Micronutrient availability: amino acids and peptides can complex micronutrients, aiding their mobility and uptake.
Rhizosphere effects: applied hydrolysates can stimulate beneficial soil and root-associated microbial activity.
Application Methods
Protein hydrolysates are applied as foliar sprays, through drip irrigation and fertigation systems, as soil drenches, and as seed or transplant treatments. Foliar and fertigation applications dominate in high-value horticulture, where growers time applications around critical stages such as transplanting, flowering and fruit set, or ahead of expected stress events. In broad-acre crops, use is more often tied to seed treatment or to tank-mixing with crop protection products and foliar nutrients, which keeps application costs down. Liquid formulations suit these application routes, while dry soluble powders and granules offer lower freight and storage costs and are used in blending and in markets with longer distribution chains.
Value Chain
Access to consistent, traceable feedstock is a structural advantage in this market. Several leading producers are located close to their raw material base, for example near tanning districts for collagen-based products, and some are vertically integrated from by-product collection through to branded product sales.
Regulatory Landscape
Regulation of biostimulants has historically been fragmented, with products sold as fertilisers, soil amendments or plant growth regulators depending on the jurisdiction and the claims made. Several major markets have moved toward dedicated frameworks in recent years.
For protein hydrolysates specifically, two regulatory themes matter most. First, the move to formal registration raises the cost of market entry and favours suppliers with established trial programmes and analytical capabilities. Second, rules on animal-derived inputs — covering processing standards, traceability, contaminants and, in some markets, ethical and religious acceptability — affect animal-based products more than plant-based ones.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Structure
The protein hydrolysate biostimulants market is fragmented. It combines specialist biostimulant and specialty nutrition companies, many of them based in Italy and Spain; hydrolysate producers integrated with the leather, meat or food processing industries; agrochemical majors that have entered through acquisitions; and a large number of regional formulators and distributors. No single company dominates globally, and leadership varies by country, crop and raw material source.
Competition centres on product consistency, the strength of efficacy evidence, regulatory approvals in each market, distribution reach and agronomic support. Ownership of feedstock and hydrolysis technology is an important advantage for producers of animal-based products, while plant-based suppliers compete on peptide characterisation, organic certification and brand recognition.
Leading Companies
The companies below are among the most active participants in protein hydrolysate and amino-acid-based biostimulants. The list is not ranked.
Key Success Factors
Secure, consistent feedstock: long-term access to traceable raw materials of stable quality.
Process control: hydrolysis technology that delivers consistent amino acid and peptide profiles from batch to batch.
Evidence base: multi-season, multi-location trial data and peer-reviewed research that support claims and registrations.
Regulatory capability: dossiers that meet the EU FPR, India FCO, Brazilian and other national requirements.
Distribution and agronomy: access to growers through distributors and technical teams able to design application programmes.
Portfolio breadth: the ability to offer both animal- and plant-based products and combination formulations.
Market estimates by geography (2032)
InsightEurope leads with $366.36M by 2032, while Asia Pacific is projected to grow fastest at a 10.9% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $81.45M | $128.85M | $202.23M | 9.5% | 19% |
| Europe | $152.05M | $236.95M | $366.36M | 9.2% | 35% |
| Asia Pacific | $86.20M | $145.43M | $243.44M | 10.9% | 23% |
| Latin America | $63.25M | $105.14M | $173.42M | 10.6% | 17% |
| Middle East & Africa | $19.94M | $32.66M | $53.08M | 10.3% | 5% |
| Total | $402.89M | $649.03M | $1.04B | 9.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.04B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Plant-based | $537.52M | 10.5% | 52% |
| Animal-based | $501.00M | 9.4% | 48% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Protein Hydrolysate Biostimulants Market covering market dynamics, competitive landscape, and strategic outlook.
The Protein Hydrolysate Biostimulants Market market is projected to reach $1.04B by 2032, growing at 9.9% CAGR. The Plant-based segment holds the largest share.
Pressure to improve nutrient use efficiency
A large share of applied nitrogen is not taken up by crops and is lost to the environment. Policy targets such as the EU Farm to Fork Strategy's aims to reduce nutrient losses by at least 50% and fertiliser use by at least 20% by 2030, together with national measures such as Germany's tightened fertiliser ordinance, push growers and advisers toward inputs that help crops make better use of applied nutrients. Nutrient use efficiency is one of the claims recognised for plant biostimulants under the EU FPR, and protein hydrolysates are among the categories most frequently positioned on this claim.
Rising incidence of abiotic stress
More frequent heat waves, droughts and erratic rainfall expose crops to stress at sensitive growth stages. Protein hydrolysates are widely used as a preventive or recovery treatment around such events, because amino acids such as proline and glycine support osmotic adjustment and antioxidant defence. This use case has broadened demand beyond growth promotion into risk management.
Growth of high-value horticulture and quality-driven supply chains
Fruit, vegetable and vineyard growers supplying retailers and export markets are paid for uniformity, size, colour and shelf life. Protein hydrolysates are used to support fruit set, sizing and quality, and the return on a relatively low-cost input is easier to demonstrate in these crops. Fruits & vegetables accounted for 55.0% of global demand in 2025.
Circular-economy use of protein-rich by-products
Hydrolysates convert by-products from the leather, meat, fish and food processing industries into higher-value agricultural inputs. This gives producers access to relatively low-cost feedstock and allows the product to be positioned as part of a circular bioeconomy, which resonates with food companies and retailers pursuing sustainability commitments.
Investment by agrochemical majors
Large crop input companies have built biologicals businesses through acquisitions and capacity investment, including Syngenta's acquisition of Valagro in 2020 and its new biostimulant plant in Orangeburg, South Carolina, designed for 16,000 tons of annual output, and Corteva's completion of the Stoller and Symborg acquisitions in March 2023. Their distribution reach and agronomic teams extend biostimulant use to growers who were previously served only by specialist suppliers.
Plant-based and organic-compatible products: plant-derived hydrolysates avoid many of the restrictions applied to animal by-products and suit organic, vegan-labelled and religiously sensitive supply chains. The segment is projected to grow at 10.4% globally.
Broad-acre crops: cereals & grains is the fastest-growing crop segment at 11.3% CAGR. Low-dose seed treatments and tank-mix compatible formulations can make use economical at scale.
High-growth geographies: India (12.8%), Asia Pacific as a whole (10.9%) and Latin America (10.5%) offer growth above the global average.
Characterised, targeted products: research into specific bioactive peptides is enabling products designed for defined responses, such as rooting or stress recovery, supported by stronger evidence.
Combination products: formulations combining hydrolysates with micronutrients, seaweed extracts or microbial inoculants allow suppliers to differentiate and to address several agronomic needs in one application.
Local production: manufacturing close to demand centres reduces freight costs for liquid products and supports registration in markets that favour locally produced inputs.
Variable field performance
Responses to protein hydrolysates vary with crop, growth stage, product composition, dose and environmental conditions. Product quality across the market is uneven, and results from one product cannot be assumed to transfer to another with a similar label. Inconsistent results reduce grower confidence and slow repeat purchase, particularly in broad-acre crops where margins are thin.
Regulatory cost and uncertainty
Formal registration regimes require multi-location efficacy trials, toxicity data and chemical characterisation. In India, the end of provisional registrations in June 2025 removed thousands of products from the legal market, leaving 146 fully approved biostimulants as of September 2025. In the United States, the absence of a federal definition means the boundary between a fertiliser claim and a plant regulator claim continues to shape what suppliers can say on labels.
Scrutiny of animal-derived inputs
Animal-based hydrolysates face additional requirements on processing, traceability and contaminants, and residual chromium in leather-derived hydrolysates has been a recurring quality concern. Acceptability is also an issue in some markets: India withdrew approval for 11 animal-based protein hydrolysate biostimulants in October 2025 after ethical, religious and dietary concerns were raised, keeping them suspended until pre-harvest interval data for foliar use are generated.
Price sensitivity in broad-acre crops
Growers of cereals, oilseeds and other commodity crops evaluate inputs on a strict cost-per-hectare basis. Without consistent yield responses, biostimulants compete for limited budgets with fertilisers and crop protection products.
Demonstrating a consistent return on investment to growers across seasons and sites.
Low-quality and mislabelled products that undermine confidence in the category.
Dependence on by-product feedstock whose availability and price are tied to the meat, leather and food processing industries.
Divergent regulatory requirements across markets, which raise the cost of multi-country product launches.
Shift toward plant-based sources: plant-based products are projected to move from a 50.0% share in 2025 to 51.8% in 2032.
Liquid formulations: liquids are projected to increase their share from 70.0% to 71.7%, supported by the spread of drip irrigation and fertigation.
Move to enzymatic processes: producers are favouring enzymatic hydrolysis for better control over amino acid and peptide profiles.
Evidence-led marketing: registration requirements and grower expectations are pushing suppliers to publish trial data and peer-reviewed research.
Consolidation: specialist biostimulant firms continue to be acquired by agrochemical and specialty chemical companies.
Regional manufacturing: suppliers are adding production in the Americas and other demand centres to shorten supply chains.
Access to consistent, traceable feedstock is a structural advantage in this market. Several leading producers are located close to their raw material base, for example near tanning districts for collagen-based products, and some are vertically integrated from by-product collection through to branded product sales.
Regulation of biostimulants has historically been fragmented, with products sold as fertilisers, soil amendments or plant growth regulators depending on the jurisdiction and the claims made. Several major markets have moved toward dedicated frameworks in recent years.
For protein hydrolysates specifically, two regulatory themes matter most. First, the move to formal registration raises the cost of market entry and favours suppliers with established trial programmes and analytical capabilities. Second, rules on animal-derived inputs — covering processing standards, traceability, contaminants and, in some markets, ethical and religious acceptability — affect animal-based products more than plant-based ones.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 106 companies operating in the Protein Hydrolysate Biostimulants Market market, including revenue, employee count, and market positioning where available.
Showing 106 of 106 companies
Company Headquarters: Indianapolis, US Founded: 1989 Workforce: ~21,100 Company Working: Corteva Agriscience develops, manufactures, and markets a wide range of products, including seeds and traits, crop protection, software, and digital solutions, seed treatments, forages, inoculants, vegetation management, pasture management, turf and ornamental, urban pest management, and oil. It is directly present in more than 50 countries and covers all major regions such as North America, Asia-Pacific, Latin America, Europe, and the Middle East & Africa. Corteva Agriscience is a subsidiary of Dow Chemical Company. Hence, the provided financial information is of the Dow Chemical Company.
4 interactive charts drawn from the Protein Hydrolysate Biostimulants Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Protein Hydrolysate Biostimulants Market By Crop Type
Global Protein Hydrolysate Biostimulants Market By Physical Form
Global Protein Hydrolysate Biostimulants Market By Raw Material Source
Global Protein Hydrolysate Biostimulants Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)